BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 22445458)

  • 1. Topical Tacrolimus and Mycophenolic Acid Therapy Synergizes with Low Dose Systemic Immunosuppression to Sustain Vascularized Composite Allograft Survival.
    Feturi FG; Zhang W; Erbas VE; Dong L; Sahin H; Zhang Z; Oksuz S; Spiess AM; Solari MG; Venkataramanan R; Gorantla VS
    J Pharm Sci; 2024 Jun; 113(6):1607-1615. PubMed ID: 38309457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The contribution of the donor vascularised hand and face allograft in transplant rejection: An immunological perspective.
    Amin KR; Fildes JE
    Transpl Immunol; 2024 Jun; 84():102035. PubMed ID: 38518826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Science of composite tissue allotransplantation.
    Swearingen B; Ravindra K; Xu H; Wu S; Breidenbach WC; Ildstad ST
    Transplantation; 2008 Sep; 86(5):627-35. PubMed ID: 18791440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Orthotopic Hind Limb Transplantation in the Mouse.
    Furtmüller GJ; Oh B; Grahammer J; Lin CH; Sucher R; Fryer ML; Raimondi G; Lee WP; Brandacher G
    J Vis Exp; 2016 Feb; (108):53483. PubMed ID: 26967527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma microRNAs Are Potential Biomarkers of Acute Rejection After Hindlimb Transplantation in Rats.
    Oda H; Ikeguchi R; Yurie H; Kaizawa Y; Ohta S; Yamamoto K; Aoyama T; Matsuda S
    Transplant Direct; 2016 Nov; 2(11):e108. PubMed ID: 27826601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Composite tissue transplantation: a rapidly advancing field.
    Ravindra KV; Wu S; Bozulic L; Xu H; Breidenbach WC; Ildstad ST
    Transplant Proc; 2008 Jun; 40(5):1237-48. PubMed ID: 18589081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nerve allotransplantation as it pertains to composite tissue transplantation.
    Moore AM; Ray WZ; Chenard KE; Tung T; Mackinnon SE
    Hand (N Y); 2009 Sep; 4(3):239-44. PubMed ID: 19306048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunosuppressive properties of mitomycin C-incubated human myeloid blood cells (MIC) in vitro.
    Dittmar L; Mohr E; Kleist C; Ehser S; Demirdizen H; Sandra-Petrescu F; Hundemer M; Opelz G; Terness P
    Hum Immunol; 2015 Jul; 76(7):480-7. PubMed ID: 26074415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Local administration of Mitomycin-C-Treated peripheral blood mononuclear cells (PBMCs) prolongs allograft survival in vascularized composite allotransplantation.
    Radu CA; Kiefer J; Gebhard MM; Bigdeli AK; Schmidt VJ; Germann G; Lehnhardt M; Terness P; Kneser U; Kremer T
    Microsurgery; 2016 Jul; 36(5):417-425. PubMed ID: 26573219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel phosphocholine-mimetic inhibits a pro-inflammatory conformational change in C-reactive protein.
    Zeller J; Cheung Tung Shing KS; Nero TL; McFadyen JD; Krippner G; Bogner B; Kreuzaler S; Kiefer J; Horner VK; Braig D; Danish H; Baratchi S; Fricke M; Wang X; Kather MG; Kammerer B; Woollard KJ; Sharma P; Morton CJ; Pietersz G; Parker MW; Peter K; Eisenhardt SU
    EMBO Mol Med; 2023 Jan; 15(1):e16236. PubMed ID: 36468184
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualised immunosuppression with intravenously administered donor-derived modified immune cells compared with standard of care in living donor kidney transplantation (TOL-2 Study): protocol for a multicentre, open-label, phase II, randomised controlled trial.
    Morath C; Schmitt A; Schmitt M; Wang L; Kleist C; Opelz G; Süsal C; Tran TH; Scherer S; Schwenger V; Kemmner S; Fischereder M; Stangl M; Hauser IA; Sommerer C; Nusshag C; Kälble F; Speer C; Benning L; Bischofs C; Sauer S; Schubert ML; Kunz A; Hückelhoven-Krauss A; Neuber B; Mehrabi A; Schwab C; Waldherr R; Sander A; Büsch C; Czock D; Böhmig GA; Reiser J; Roers A; Müller-Tidow C; Terness P; Zeier M; Daniel V; Schaier M
    BMJ Open; 2022 Nov; 12(11):e066128. PubMed ID: 36368749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I trial of donor-derived modified immune cell infusion in kidney transplantation.
    Morath C; Schmitt A; Kleist C; Daniel V; Opelz G; Süsal C; Ibrahim E; Kälble F; Speer C; Nusshag C; Pego da Silva L; Sommerer C; Wang L; Ni M; Hückelhoven-Krauss A; Czock D; Merle U; Mehrabi A; Sander A; Hackbusch M; Eckert C; Waldherr R; Schnitzler P; Müller-Tidow C; Hoheisel JD; Mustafa SA; Alhamdani MS; Bauer AS; Reiser J; Zeier M; Schmitt M; Schaier M; Terness P
    J Clin Invest; 2020 May; 130(5):2364-2376. PubMed ID: 31990685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell therapy for immunosuppression after kidney transplantation.
    Morath C; Schmitt A; Zeier M; Schmitt M; Sandra-Petrescu F; Opelz G; Terness P; Schaier M; Kleist C
    Langenbecks Arch Surg; 2015 Jul; 400(5):541-50. PubMed ID: 26077202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitomycin-C-treated peripheral blood mononuclear cells (PBMCs) prolong allograft survival in composite tissue allotransplantation.
    Radu CA; Kiefer J; Horn D; Kleist C; Dittmar L; Sandra F; Rebel M; Ryssel H; Koellensperger E; Gebhard MM; Lehnhardt M; Germann G; Terness P
    J Surg Res; 2012 Aug; 176(2):e95-e101. PubMed ID: 22445458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Donor-derived transplant acceptance-inducing cells in composite tissue allotransplantation.
    Radu CA; Horn D; Kiefer J; Rebel M; Gebhard MM; Ryssel H; Köllensperger E; Fändrich F; Germann G; Kremer T
    J Plast Reconstr Aesthet Surg; 2012 Dec; 65(12):1684-91. PubMed ID: 22841770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The combination of mitomycin-induced blood cells with a temporary treatment of ciclosporin A prolongs allograft survival in vascularized composite allotransplantation.
    Radu CA; Fischer S; Diehm Y; Hetzel O; Neubrech F; Dittmar L; Kleist C; Gebhard MM; Terness P; Kneser U; Kiefer J
    Langenbecks Arch Surg; 2018 Feb; 403(1):83-92. PubMed ID: 28823033
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells enhance the induction of mixed chimerism and tolerance to rat hind-limb allografts after bone marrow transplantation.
    Pan H; Zhao K; Wang L; Zheng Y; Zhang G; Mai H; Han Y; Yang L; Guo S
    J Surg Res; 2010 May; 160(2):315-24. PubMed ID: 19524257
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.